Natural history of human breast cancer: Recent data and clinical implications Maurice TubianaSerge Koscielny 13th San Antonio Breast Cancer Symposium — Plenary Lecture Pages: 125 - 140
Proliferative inhibition of human breast carcinoma cells by high concentration estradiol does not alter radiosensitivity David E. WazerMelita JoyceRupert Schmidt-Ullrich Report Pages: 141 - 148
Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67 W. WeikelT. BeckP. G. Knapstein Report Pages: 149 - 154
Coordinated expression of intermediate biomarkers for tumorigenic transformation in RAS-transfected mouse mammary epithelial cells Nitin T. TelangRamaswamy NarayananMichael P. Osborne Report Pages: 155 - 163
Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer Janet E. MacheledtAman U. BuzdarFrankie Ann Holmes Report Pages: 165 - 170
A phase I/II study of high-dose megestrol acetate in the treatment of metastatic breast cancer Howard L. ParnesJeffrey S. AbramsJoseph Aisner Report Pages: 171 - 177
Duct endoscopy and endoscopic biopsy in the evaluation of nipple discharge Masujiro MakitaGoi SakamotoMotoko Ikenaga Report Pages: 179 - 187
Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer Liesbeth BergmanGert DekkerFlora E. van Leeuwen Report Pages: 189 - 198